Analyze Diet
Domestic animal endocrinology2009; 38(4); 253-259; doi: 10.1016/j.domaniend.2009.11.004

Platelet-derived growth factor acts via both the Rho-kinase and p38 signaling enzymes to stimulate contraction in an in vitro model of equine wound healing.

Abstract: Horses are more prone to complications in the wound healing process than other species, and problems such as chronic inflammation, delayed epithelialization, poor wound contraction, and exuberant granulation tissue are commonly seen, particularly in wounds on the distal limbs. In comparison, wounds of the oral mucosa heal rapidly in a scarless fashion with a high degree of wound contraction. The effect of platelet-derived growth factor BB (PDGF), insulin-like growth factor (IGF)-1, and transforming growth factor beta1 (TGFbeta1) on the contraction of a fibroblast-populated collagen matrix (FPCM) as a model of equine wound contraction was investigated using equine oral fibroblasts. The fibroblasts were embedded into floating FPCM and treated with PDGF, IGF-1, and TGFbeta1. The surface areas of the FPCM were determined daily for 5 d. Platelet-derived growth factor significantly stimulated the contraction of the FPCM at an optimal concentration of 10 ng/mL (P=0.025). Insulin-like growth factor-1 and TGFbeta1 did not significantly affect the contraction of the FPCM relative to the control. To elucidate the mechanisms by which PDGF stimulated contraction of FPCM, the Rho-kinase and p38 cell signaling pathways were blocked, resulting in a significant inhibition (P<0.001) of PDGF-stimulated contraction. Platelet-derived growth factor BB is a potent stimulator of fibroblast migration, and hence the FPCM contraction generated here is probably a result of its effects on cell migration. The results of the present experiment suggest that this effect is stimulated via both the Rho-kinase and p38 signaling pathways in equine oral fibroblasts.
Publication Date: 2009-12-06 PubMed ID: 20036481DOI: 10.1016/j.domaniend.2009.11.004Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates how Platelet-derived growth factor (PDGF) influences contraction in horse wound healing model, specifically on equine oral fibroblasts. This study reveals that PDGF is a vital stimulant for fibroblast migration, promoting wound contraction, and that it uses the Rho-kinase and p38 signaling pathways to function.

Introduction

  • The study focuses on wound healing in horses, particularly issues such as chronic inflammation, delayed mucosal repair, poor wound contraction, and excessive granulation tissue growth. These problems are especially prevalent in wounds located on the distal limbs of horses, whereas oral mucosal wounds tend to heal rapidly, with significant wound contraction and without scarring.

Research Methodology

  • The researchers created an in vitro model of equine wound contraction using a fibroblast-populated collagen matrix (FPCM) populated with equine oral fibroblasts.
  • The fibroblasts were treated with Platelet-derived growth factor BB (PDGF), Insulin-like growth factor (IGF)-1, and Transforming growth factor beta1 (TGFbeta1).
  • Over five days, the surface areas of the FPCM were measured daily to determine the rate of contraction.

Findings

  • PDGF was found to significantly stimulate the contraction of the FPCM at an optimal concentration of 10 ng/mL. IGF-1 and TGFbeta1, however, did not significantly affect the contraction of the FPCM in relation to the control sample.
  • To understand the mechanism behind PDGF-stimulated contraction, the researchers blocked the Rho-kinase and p38 cell signaling pathways, resulting in a significant decrease in PDGF-stimulated contraction. This suggests that PDGF uses these pathways to stimulate contraction.

Conclusion

  • PDGF was identified as a key stimulator of fibroblast migration, which likely leads to the FPCM contraction observed here.
  • The findings suggest that PDGF’s effect is stimulated via both the Rho-kinase and p38 signaling pathways in equine oral fibroblasts, providing valuable insight for future research into equine wound healing therapies.

Cite This Article

APA
Watts EJ, Rose MT. (2009). Platelet-derived growth factor acts via both the Rho-kinase and p38 signaling enzymes to stimulate contraction in an in vitro model of equine wound healing. Domest Anim Endocrinol, 38(4), 253-259. https://doi.org/10.1016/j.domaniend.2009.11.004

Publication

ISSN: 1879-0054
NlmUniqueID: 8505191
Country: United States
Language: English
Volume: 38
Issue: 4
Pages: 253-259

Researcher Affiliations

Watts, E J
  • Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Aberystwyth, Ceredigion, United Kingdom. mir@aber.ac.uk
Rose, M T

    MeSH Terms

    • Animals
    • Cell Movement
    • Cells, Cultured
    • Enzyme Inhibitors / pharmacology
    • Fibroblasts
    • Horses
    • Insulin-Like Growth Factor I / pharmacology
    • Models, Biological
    • Mouth Mucosa
    • Platelet-Derived Growth Factor / pharmacology
    • Signal Transduction
    • Transforming Growth Factor beta1 / pharmacology
    • Wound Healing / drug effects
    • Wound Healing / physiology
    • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
    • p38 Mitogen-Activated Protein Kinases / physiology
    • rho-Associated Kinases / antagonists & inhibitors
    • rho-Associated Kinases / physiology